수백만 명을 구할 잠재력과 큰 수익 기회가 공존하는 종목 [DRTS] 🚀

Not AI slop, good write-up OP.

This is the dream scenario, do good for man kind and make money, nothing better then that in the world

**Upcoming catalysts for DRTS:**

**PMDA approval in Japan**
Announced last week, further details and progress to come

**Keytruda trial for combination therapy**
Updates from combination trials with Merck’s Keytruda, exploring systemic and metastatic potential

**GBM FDA trial**
Two months ago it was announced Alpha Tau has successfully treated the first GBM patient, historic news, with more patients and updates coming every month - including recent update about the second patient being successfully treated and both patients doing great

**FDA Pancreas trial**
Earlier than that it was announced that Alpha Tau has successfully treated a Pancreatic Cancer patient as well, after successfully completing a Pancreatic Cancer study with tens of patients in Canada. Progress and updates from the Pancreas trial could be shared along the way

**Phase 3 recruitment completion for cSCC**
Q1 2026, the early results are amazing

**cSCC FDA approval submission**
Already started submitting the data

**New FDA trials launching**
Most recently prostate, while next could be head & neck

**Commercial manufacturing facility completion**
Already approved by the FDA

**Presenting at more conferences**
Including Sidoti Conference in a couple of weeks, RTH & Co Radiopharma Landscape conference and others

**Other stock related events**
Potential strategic partnerships or licensing deals, enabled by regulatory and manufacturing readiness.
Investor re ratings, like H.C. Wainwright raising price target to 12$, transitioning from pre revenue clinical stage to commercial oncology company is a major re-rating moment.
Future label expansions leveraging existing approvals and platform scalability.

Thanks for sharing. I want to believe in this company's mission, and I like the progress they've made so far from your summary. I'll look more into it, probably will start investing a bit into them.

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:**

‏FDA Breakthrough Device Designation

‏FDA TAP program inclusion

‏FDA MDSAP certification

‏FDA IDE’s for five cancers and counting

‏FDA PHASE 3 completion in Q1 2026

‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types)

‏FDA approval for commercial factory in the US, with other factories built and more in planing

⁠100% tumor response rate in early FDA trials

‏Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc…

‏Activates immune system

PMDA approval in Japan

⁠55+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…)

‏Patents, IP and more…

What makes Alpha Tau interesting to me is that it’s not just a theoretical biotech story they already have PMDA approval in Japan, Breakthrough Device status with the FDA, multiple trials running, and manufacturing in place. If the upcoming Phase 3 and pancreatic and GBM data continue to look good, the risk reward here could be really solid.

I will probably sound like a bitch but if people truly believed they found a gem to make them millions, why would they post it online? Most people would want to keep it to themselves, unless the goal is to pump the stock I guess.

I’ve been looking for a new stock that is for a good cause. Thanks op.

Does it being headquartered in israel be an issue ?

Zero debt and $76M in cash for a biotech with this much progress is insane. I mean, seriously ZERO DEBT!!!

the keytruda combo results are hard to ignore tbh, 19% to near 100% response rate is the kind of number that either changes everything or falls apart in a larger sample.. watching this one closely.

Sorry - the post you're trying to make mentions a stock that currently breaks rule #7.

Any of the following criteria is considered breaking the rule:


* Typically trades under $5 or previously traded under $5 within 6 months

* Below $300 million market cap or previously traded under 300m before the pump within 6 months

* Most OTC / PINK stocks

* Usually has missed reporting/filings; no auditing or odd auditing issues

* Low volume or wide bid/ask spread

* Doesn't have any big name institutional holders

* If the biggest institutional holder is a stock promoter then they don't count as an institutional holder

* All SPACs

You can learn more about rule #7 here: https://www.reddit.com/r/stocks/wiki/pennystocks

This sounds a lot like Immunity Bio (IBRX)

Interesting. What do you think is a good entry point for this?

TL;DR buy my bags

Still trying to pump this for at least 2 weeks?

If I’m buying cancer, I’m buying SONA nanotech, 80% success rate